Scientists have developed a new class of microscopic antibody fragments capable of functioning inside human cells, overcoming a long-standing limitation in biomedical science.
Despite its enormous global burden, osteoarthritis has no licensed disease-modifying treatments, and available analgesics have moderate efficacy and substantial side-effects.1 The success of ...
Fusarium head blight (FHB) is a destructive disease of wheat that can reduce grain yields and contaminate grain with toxins ...
Lineage’s COR1 targets restoration of endothelial pump function via intracameral delivery and adhesion to Descemet membrane, ...
Owned Asset Benefits From Existing Ophthalmology and Manufacturing ExpertiseFuchs Endothelial Corneal Dystrophy (FECD) ...
R&D Expenses: Research and development (R&D) expenses were $13.4 million for the quarter ended December 31, 2025, and $59.1 million for the year ended December 31, 2025. G&A Expenses: General and ...
Shares of Dyne Therapeutics gained after the company shared positive data from a continuing trial of a potential Duchenne muscular dystrophy treatment. The stock rose 14%, to $16.93, midday Monday.
Additional analyses highlight new findings related to decline in muscle contractile area and median age at loss of ambulation with givinostat CONCORD, Mass., March 9, 2026 /PRNewswire/ -- ITF ...
- New analyses out to 24-months showed improvement in heart and lung function compared to expected declines in DMD natural history - - Data expand on previously reported results demonstrating that ...
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors ...
New York Attorney General Letitia James is instructing a Manhattan hospital to resume offering gender-transition treatment to transgender youth after it ended such treatments last month over funding ...
JACKSONVILLE, Fla. – Prostate cancer is the most common cancer in men in the U.S. after skin cancer, but it is often slow-growing and highly treatable. Now there is a minimally invasive treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results